Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
HK Stock Market Move | SUNART RETAIL (06808) increases by more than 3%, UBS is optimistic about the company's transformation plan, and RT-Mart's product strength is expected to improve.
HK Stock Market Move | Legend Upstar (00459) resumed trading and soared more than 60%. The chairman offered a premium of approximately 77.33% for privatization.
Caitong: Crude oil's big cycle depends on supply clearing, with the current Q4 peak season catalyzing it.
HK Stock Market Move | SUNART RETAIL (06808) increases by more than 3%, UBS is optimistic about the company's transformation plan, and RT-Mart's product strength is expected to improve.
HK Stock Market Move | Legend Upstar (00459) resumed trading and soared more than 60%. The chairman offered a premium of approximately 77.33% for privatization.
Caitong: Crude oil's big cycle depends on supply clearing, with the current Q4 peak season catalyzing it.
RECOMMEND
Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025
Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025
As The 2025 Central Economic Work Conference Approaches, What New Expectations Lie Ahead For Next Year’s Economic Agenda? Institutions Forecast Five Key Highlights
08/12/2025
